Max’s recent stories

By Andriy Rovenchak, Max DruchokOct 02, 2024
Healthcare & Life Sciences•
NVIDIA•
R&D

Vielversprechende Ergebnisse in der Entwicklung neuer Arzneimittel durch ML

Erfahren Sie, wie fortschrittliche ML-Methoden und Partnerschaften die Wirkstoffentdeckung beschleunigen.

clock-icon-black  10 min read
By Max Druchok, Marta Strohush (Pinyazhko)May 25, 2023
Healthcare & Life Sciences•
R&D

The Tech (R)evolution in Life Sciences

SoftServe empowers companies to go beyond existing barriers to discover solutions—saving time and money.

clock-icon-black  10 min read
By Max Druchok, Oleksandr GurbychMar 23, 2020
R&D

Protein-Peptide Docking

Learn more about our end-to-end molecular docking pipeline that combines deep learning and DFT approaches to predict protein-peptide docking.

clock-icon-black  2 min read